Compositions, devices and methods for treating autism

作者: Borody Thomas Julius

DOI:

关键词:

摘要: The present invention relates to a method for treating, ameliorating, reversing and/or preventing autism or an spectrum disorder (ASD) via the administration of formulation, pharmaceutical preparation composition comprising consisting of: (a) rifaximin (optionally XIFAXAN, XIFAXANTA NORMIXT), extended intestinal release (EIR) rifaximin, rifamycin derivative, rifampicin (or rifampin) RIFADIN), rifabutin MYCOBUTIN), rifapentine PRIFTIN), rifalazil, bicozamycin, mixture combination thereof, (b) NORMIX) and at least one additional antimicrobial antibiotic agent, wherein optionally agent comprises vancomycin, metronidazole FLAGYLTM, METROTM), tinidazole FASIGYN, SIMPLOTAN, TINDAMAX) thereof

参考文章(9)
Thomas Julius Borody, Novel enteric combination therapy ,(2010)
Richard H. Sandler, Sydney M. Finegold, Ellen R. Bolte, Cathleen P. Buchanan, Anne P. Maxwell, Marja-Liisa Väisänen, Michael N. Nelson, Hannah M. Wexler, Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology. ,vol. 15, pp. 429- 435 ,(2000) , 10.1177/088307380001500701
Mady Hornig, W. Ian Lipkin, Brent L. Williams, Autism-associated biomarkers and uses thereof ,(2013)
Siobhain M. O’ Mahony, Roman M. Stilling, Timothy G. Dinan, John F. Cryan, The microbiome and childhood diseases: Focus on brain-gut axis. Birth Defects Research Part C-embryo Today-reviews. ,vol. 105, pp. 296- 313 ,(2015) , 10.1002/BDRC.21118